Literature DB >> 3283655

The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.

M D Erisman1, J K Scott, R A Watt, S M Astrin.   

Abstract

In this study, we have employed both indirect immunofluorescence and ELISA assays to compare the relative levels of c-myc protein in cell lines derived from normal human colon and colon adenocarcinomas. We show that the levels of protein found in the majority of carcinoma cell lines are consistent with the levels of mRNA expressed, and that both are significantly elevated with respect to the levels found in normal cells. Growing populations of fibroblastic and epithelial cell lines derived from normal colonic mucosa exhibit small numbers of steady-state transcripts and immunofluorescence signals which are weak and confined to the nucleus. The adenocarcinoma cell lines, however, express 5- to 10-fold elevated levels of c-myc mRNA and exhibit correspondingly intense immunofluorescence signals which appear to reside principally in the nucleus. Quantitation of c-myc protein levels in these tumor cell lines by ELISA assay indicates that they are 8- to 37-fold higher than the levels of protein in normal cells. Elevated expression of the c-myc gene at both the mRNA and protein levels occurs constitutively in the colorectal carcinoma cell lines during their growth in culture, in contrast to the transiently elevated levels of expression observed in normal cells which have been subjected to a mitogenic stimulus. The constitutively elevated expression of the c-myc protein in colorectal carcinoma cell lines is not typically accompanied by gross rearrangement or amplification of the gene.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3283655

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression.

Authors:  S Mai; J Hanley-Hyde; G J Rainey; T I Kuschak; J T Paul; T D Littlewood; H Mischak; L M Stevens; D W Henderson; J F Mushinski
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.

Authors:  F T Kolligs; B Kolligs; K M Hajra; G Hu; M Tani; K R Cho; E R Fearon
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

3.  Posttranscriptional regulation of c-myc proto-oncogene expression and growth inhibition by recombinant human interferon-beta ser17 in a human colon carcinoma cell line.

Authors:  D Chatterjee; T M Savarese
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.

Authors:  T Shimada; K Kojima; K Yoshiura; H Hiraishi; A Terano
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

5.  Evidence that the familial adenomatous polyposis gene is involved in a subset of colon cancers with a complementable defect in c-myc regulation.

Authors:  M D Erisman; J K Scott; S M Astrin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors.

Authors:  B Roy; J Beamon; E Balint; D Reisman
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

7.  Differential pp60c-src activity in well and poorly differentiated human colon carcinomas and cell lines.

Authors:  T K Weber; G Steele; I C Summerhayes
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  c-myc protein distribution. Neoplastic tissues of the human colon.

Authors:  N Tulchin; L Ornstein; N Harpaz; J Guillem; C Borner; K O'Toole
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

9.  Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element.

Authors:  Joshua P Frederick; Nicole T Liberati; David S Waddell; Yigong Shi; Xiao-Fan Wang
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

10.  Suppression of deregulated c-MYC expression in human colon carcinoma cells by chromosome 5 transfer.

Authors:  C Rodriguez-Alfageme; E J Stanbridge; S M Astrin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.